Cargando…

Proteomics in Pancreatic Cancer Research

Pancreatic cancer is a highly aggressive malignancy with a poor prognosis and deeply affects the life of people. Therefore, the earlier diagnosis and better treatments are urgently needed. In recent years, the proteomic technologies are well established and growing rapidly and have been widely appli...

Descripción completa

Detalles Bibliográficos
Autores principales: Geng, Ruihui, Li, Zhaoshen, Li, Shude, Gao, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3200191/
https://www.ncbi.nlm.nih.gov/pubmed/22084685
http://dx.doi.org/10.1155/2011/365350
_version_ 1782214667816402944
author Geng, Ruihui
Li, Zhaoshen
Li, Shude
Gao, Jun
author_facet Geng, Ruihui
Li, Zhaoshen
Li, Shude
Gao, Jun
author_sort Geng, Ruihui
collection PubMed
description Pancreatic cancer is a highly aggressive malignancy with a poor prognosis and deeply affects the life of people. Therefore, the earlier diagnosis and better treatments are urgently needed. In recent years, the proteomic technologies are well established and growing rapidly and have been widely applied in clinical applications, especially in pancreatic cancer research. In this paper, we attempt to discuss the development of current proteomic technologies and the application of proteomics to the field of pancreatic cancer research. This will explore the potential perspective in revealing pathogenesis, making the diagnosis earlier and treatment.
format Online
Article
Text
id pubmed-3200191
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-32001912011-11-14 Proteomics in Pancreatic Cancer Research Geng, Ruihui Li, Zhaoshen Li, Shude Gao, Jun Int J Proteomics Review Article Pancreatic cancer is a highly aggressive malignancy with a poor prognosis and deeply affects the life of people. Therefore, the earlier diagnosis and better treatments are urgently needed. In recent years, the proteomic technologies are well established and growing rapidly and have been widely applied in clinical applications, especially in pancreatic cancer research. In this paper, we attempt to discuss the development of current proteomic technologies and the application of proteomics to the field of pancreatic cancer research. This will explore the potential perspective in revealing pathogenesis, making the diagnosis earlier and treatment. Hindawi Publishing Corporation 2011 2011-08-14 /pmc/articles/PMC3200191/ /pubmed/22084685 http://dx.doi.org/10.1155/2011/365350 Text en Copyright © 2011 Ruihui Geng et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Geng, Ruihui
Li, Zhaoshen
Li, Shude
Gao, Jun
Proteomics in Pancreatic Cancer Research
title Proteomics in Pancreatic Cancer Research
title_full Proteomics in Pancreatic Cancer Research
title_fullStr Proteomics in Pancreatic Cancer Research
title_full_unstemmed Proteomics in Pancreatic Cancer Research
title_short Proteomics in Pancreatic Cancer Research
title_sort proteomics in pancreatic cancer research
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3200191/
https://www.ncbi.nlm.nih.gov/pubmed/22084685
http://dx.doi.org/10.1155/2011/365350
work_keys_str_mv AT gengruihui proteomicsinpancreaticcancerresearch
AT lizhaoshen proteomicsinpancreaticcancerresearch
AT lishude proteomicsinpancreaticcancerresearch
AT gaojun proteomicsinpancreaticcancerresearch